We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

64 hedge funds and large institutions have $322M invested in Arcus Biosciences in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 14

11% more capital invested

Capital invested by funds: $290M → $322M (+$32.3M)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

2.64% less ownership

Funds ownership: 60.56% → 57.92% (-2.6%)

4% less funds holding

Funds holding: 67 → 64 (-3)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

Holders
64
Holders Change
-3
Holders Change %
-4.48%
% of All Funds
1.38%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
8
Increased
22
Reduced
14
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$4.33M
2
BlackRock
BlackRock
New York
+$1.19M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$518K
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$459K
5
State Street
State Street
Massachusetts
+$338K

Top Sellers

Rank Fund Capital Flow
1
FCMI
Foresite Capital Management III
California
-$7.18M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.17M
3
EC
EcoR1 Capital
California
-$2.53M
4
PHS
PFM Health Sciences
California
-$2.38M
5
ACM
Aisling Capital Management
New York
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$593K -$30.4K -2,800 -6%
Goldman Sachs
27
Goldman Sachs
New York
$551K +$44.2K +4,074 +10%
Swiss National Bank
28
Swiss National Bank
Switzerland
$540K – – –
State of Wisconsin Investment Board
29
State of Wisconsin Investment Board
Wisconsin
$528K +$459K +42,300 New
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$494K -$3.33K -307 -0.8%
Deutsche Bank
31
Deutsche Bank
Germany
$490K -$17.6K -1,623 -4%
B
32
Bailard
California
$478K +$144K +13,300 +53%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$390K +$270K +24,900 +395%
Bank of America
34
Bank of America
North Carolina
$346K +$74.1K +6,825 +33%
AllianceBernstein
35
AllianceBernstein
Tennessee
$271K +$118K +10,900 +101%
AIG
36
American International Group
New York
$250K -$7.05K -650 -3%
CS
37
Credit Suisse
Switzerland
$227K +$54.2K +4,996 +38%
Citadel Advisors
38
Citadel Advisors
Florida
$219K +$190K +17,519 New
OAM
39
Oxford Asset Management
United Kingdom
$206K -$180K -16,546 -50%
TI
40
Trexquant Investment
Connecticut
$204K +$178K +16,361 New
MIM
41
MetLife Investment Management
New Jersey
$195K – – –
GCP
42
GSA Capital Partners
United Kingdom
$173K +$150K +13,851 New
VOYA Investment Management
43
VOYA Investment Management
Georgia
$162K – – –
Bank of Montreal
44
Bank of Montreal
Ontario, Canada
$150K +$125K +11,556 +2,591%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$149K +$130K +11,943 New
Citigroup
46
Citigroup
New York
$141K -$1.3K -120 -1%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$137K – – –
Barclays
48
Barclays
United Kingdom
$131K +$96.3K +8,871 +554%
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$126K -$14.5K -1,334 -12%
Morgan Stanley
50
Morgan Stanley
New York
$125K -$443K -40,846 -80%
1
2
3

RCUS Hedge Fund Activity: Q1 2019 in Review

64 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q1 2019, worth a combined $322M — up 11% from $290M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of RCUS and 8 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 22 added.

The largest buyer was BVF Inc, adding an estimated $4.33M. The largest seller was Foresite Capital Management III, cutting an estimated $7.18M.

  • 64 institutional investors held Arcus Biosciences (RCUS) as of Q1 2019, down from 67 in Q4 2018.
  • Funds reported $322M of Arcus Biosciences stock for Q1 2019, up 11% quarter-over-quarter.
  • 8 funds opened new Arcus Biosciences positions in Q1 2019 and 11 closed out, a net change of -3 holders.
  • The largest Arcus Biosciences buyer in Q1 2019 was BVF Inc, an estimated $4.33M added.
  • The largest Arcus Biosciences seller in Q1 2019 was Foresite Capital Management III, an estimated $7.18M sold.

Based on aggregated 13F filings for Q1 2019.